Cargando…
Identification of a novel immune checkpoint molecule V-set immunoglobulin domain-containing 4 that leads to impaired immunity infiltration in pancreatic ductal adenocarcinoma
BACKGROUND: Checkpoint-based immunotherapy has failed to elicit responses in the majority of patients with pancreatic cancer. In our study, we aimed to identify the role of a novel immune checkpoint molecule V-set Ig domain-containing 4 (VSIG4) in pancreatic ductal adenocarcinoma (PDAC). METHODS: On...
Autores principales: | Jiang, Yongsheng, Han, Lijie, Yang, Jian, Yang, Minwei, Zhang, Jian, Xue, Meilin, Zhu, Youwei, Xiong, Cheng, Shi, Minmin, Zhao, Shiwei, Shen, Baiyong, Xu, Zhiwei, Jiang, Lingxi, Chen, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361881/ https://www.ncbi.nlm.nih.gov/pubmed/37097516 http://dx.doi.org/10.1007/s00262-023-03438-y |
Ejemplares similares
-
LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability
por: Han, Lijie, et al.
Publicado: (2023) -
Tumor-associated macrophages promote pancreatic ductal adenocarcinoma progression by inducing epithelial-to-mesenchymal transition
por: Xiong, Cheng, et al.
Publicado: (2021) -
Cystatin B increases autophagic flux by sustaining proteolytic activity of cathepsin B and fuels glycolysis in pancreatic cancer: CSTB orchestrates autophagy and glycolysis in PDAC
por: Jiang, Yongsheng, et al.
Publicado: (2022) -
DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jianyu, et al.
Publicado: (2019) -
Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment
por: Xue, Meilin, et al.
Publicado: (2023)